(2S,4R)-1-((S)-2-(6-(12-(4-(2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-12-oxododecanamido)hexanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

ID: ALA4750951

Chembl Id: CHEMBL4750951

PubChem CID: 162652109

Max Phase: Preclinical

Molecular Formula: C60H78FN9O8S

Molecular Weight: 1104.40

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCNC(=O)CCCCCCCCCCC(=O)N2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C60H78FN9O8S/c1-40-54(79-39-64-40)43-26-23-41(24-27-43)37-63-57(76)50-36-44(71)38-70(50)59(78)55(60(2,3)4)65-52(73)21-13-11-17-29-62-51(72)20-12-9-7-5-6-8-10-14-22-53(74)68-30-32-69(33-31-68)58(77)47-34-42(25-28-48(47)61)35-49-45-18-15-16-19-46(45)56(75)67-66-49/h15-16,18-19,23-28,34,39,44,50,55,71H,5-14,17,20-22,29-33,35-38H2,1-4H3,(H,62,72)(H,63,76)(H,65,73)(H,67,75)/t44-,50+,55-/m1/s1

Standard InChI Key:  BLRXMETYTMSLHB-SJZQNCIOSA-N

Alternative Forms

  1. Parent:

    ALA4750951

    ---

Associated Targets(Human)

MDA-MB-436 (532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PARP1 Tclin VHL/PARP1 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1104.40Molecular Weight (Monoisotopic): 1103.5678AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Cao C,Yang J,Chen Y,Zhou P,Wang Y,Du W,Zhao L,Chen Y.  (2020)  Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers.,  63  (19): [PMID:32924477] [10.1021/acs.jmedchem.0c00821]

Source